查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1434232

基于人工智慧的临床试验市场：按组成部分、特征、阶段、技术、应用和最终用户 - 2024-2030 年全球预测

AI-based Clinical Trials Market by Component (Services, Software), Function (Adverse Event Detection, Data Collection & Analysis, Patient Recruitment & Screening), Phase, Technology, Application, End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

基于人工智慧的临床试验市场规模预计2023年为65.2亿美元，2024年达到77.3亿美元，预计2030年将达到217.9亿美元，复合年增长率为18.79%。

基于人工智慧的临床试验的全球市场

主要市场统计
基准年[2023] 65.2亿美元
预测年份 [2024] 77.3亿美元
预测年份 [2030] 217.9亿美元
复合年增长率（%） 18.79%
基于AI的临床试验市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估基于AI的临床试验市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对基于人工智慧的临床试验市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-基于人工智慧的临床试验市场的市场规模和预测是多少？

2-在基于人工智慧的临床试验市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3-基于人工智慧的临床试验市场的技术趋势和法律规范是什么？

4-基于人工智慧的临床试验市场主要供应商的市场占有率是多少？

5-进入人工智慧临床试验市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 需要人工智慧来帮助加速和改进临床试验
      • 越来越需要降低医疗成本和硬体成本
      • 大多数製药公司越来越多地采用基于人工智慧的药物开发技术
    • 抑制因素
      • 缺乏个人参与导致失业率上升
      • 诊断不良的可能性
    • 机会
      • 基于人工智慧的临床试验的技术进步和创新
      • 主要製药公司越来越多地与人工智慧供应商建立合资企业和合作伙伴关係。
    • 任务
      • 对引入 EHR互通性的担忧
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章基于人工智慧的临床试验市场：按组成部分

  • 服务
  • 软体

第七章 人工智慧的临床试验市场：依功能分类

  • 不利事件检测
  • 资料收集与分析
  • 病人招募和筛检
  • 预测模型
  • 试验设计与最佳化

第八章基于人工智慧的临床试验市场分阶段

  • 第一阶段
  • 第二阶段
  • 第三阶段

第九章基于人工智慧的临床试验市场：按技术分类

  • 机器学习
  • 自然语言处理

第10章基于人工智慧的临床试验市场：按应用分类

  • 心血管疾病
  • 感染疾病
  • 代谢性疾病
  • 神经系统疾病
  • 肿瘤学

第十一章 以人工智慧为基础的临床试验市场：依最终使用者分类

  • 学术研究所
  • 合约研究组织
  • 医院
  • 製药和生物製药公司

第十二章美洲人工智慧临床试验市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太地区基于人工智慧的临床试验市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章 欧洲、中东和非洲人工智慧临床试验市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：按主要企业划分
  • 主要企业竞争情境分析

第16章竞争组合

  • 主要公司简介
    • AiCure, LLC
    • Aiforia Technologies Oyj
    • Antidote Technologies, Inc.
    • Ardigen SA
    • Avantor, Inc.
    • BioAge Labs
    • BioSymetrics Inc.
    • Deep 6 AI Inc.
    • Envisagenics
    • Euretos Services BV
    • Exscientia PLC
    • GNS Healthcare
    • Google LLC by Alphabet Inc.
    • Innoplexus AG
    • InSilico Medicine
    • Intel Corporation
    • International Business Machines Corporation
    • Koninklijke Philips NV
    • Median Technologies
    • Nuritas Limited
    • Pharmaceutical Pipeline Enhancement Strategies, LLC
    • Saama Technologies, Inc.
    • Symplr Software LLC
    • Trials.ai, Inc. by ZS Associates, Inc.
    • Unlearn.AI, Inc.
  • 主要产品系列

第十七章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-035590448097

[190 Pages Report] The AI-based Clinical Trials Market size was estimated at USD 6.52 billion in 2023 and expected to reach USD 7.73 billion in 2024, at a CAGR 18.79% to reach USD 21.79 billion by 2030.

Global AI-based Clinical Trials Market

KEY MARKET STATISTICS
Base Year [2023] USD 6.52 billion
Estimated Year [2024] USD 7.73 billion
Forecast Year [2030] USD 21.79 billion
CAGR (%) 18.79%
AI-based Clinical Trials Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the AI-based Clinical Trials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the AI-based Clinical Trials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the AI-based Clinical Trials Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Aiforia Technologies Oyj, Antidote Technologies, Inc., Ardigen S.A., Avantor, Inc., BioAge Labs, BioSymetrics Inc., Deep 6 AI Inc., Envisagenics, Euretos Services BV, Exscientia PLC, GNS Healthcare, Google LLC by Alphabet Inc., Innoplexus AG, InSilico Medicine, Intel Corporation, International Business Machines Corporation, Koninklijke Philips N.V., Median Technologies, Nuritas Limited, Pharmaceutical Pipeline Enhancement Strategies, LLC, Saama Technologies, Inc., Symplr Software LLC, Trials.ai, Inc. by ZS Associates, Inc., and Unlearn.AI, Inc..

Market Segmentation & Coverage

This research report categorizes the AI-based Clinical Trials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Services
    • Software
  • Function
    • Adverse Event Detection
    • Data Collection & Analysis
    • Patient Recruitment & Screening
    • Predictive Modeling
    • Trial Design & Optimization
  • Phase
    • Phase-I
    • Phase-II
    • Phase-III
  • Technology
    • Machine Learning
    • Natural Language Processing
  • Application
    • Cardiovascular Diseases
    • Infectious Diseases
    • Metabolic Diseases
    • Neurological Diseases
    • Oncology
  • End-user
    • Academic & Research Institutes
    • Contract Research Organization
    • Hospitals
    • Pharmaceutical & Biopharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the AI-based Clinical Trials Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the AI-based Clinical Trials Market?

3. What are the technology trends and regulatory frameworks in the AI-based Clinical Trials Market?

4. What is the market share of the leading vendors in the AI-based Clinical Trials Market?

5. Which modes and strategic moves are suitable for entering the AI-based Clinical Trials Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. AI-based Clinical Trials Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for artificial Intelligence which helps in boosting and improving clinical trials
      • 5.1.1.2. Rising needs to reduce healthcare costs and declining hardware costs
      • 5.1.1.3. Increased adoption of AI-based drug development technology by most of the pharmaceutical companies
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of personal involvement leading to a rise in unemployment rates
      • 5.1.2.2. Possibility of a defective diagnosis
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and innovations in AI-based clinical trials
      • 5.1.3.2. Major pharmaceutical companies are ensuring more joint ventures and partnerships with AI vendors
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the adoption of EHR interoperability
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. AI-based Clinical Trials Market, by Component

  • 6.1. Introduction
  • 6.2. Services
  • 6.3. Software

7. AI-based Clinical Trials Market, by Function

  • 7.1. Introduction
  • 7.2. Adverse Event Detection
  • 7.3. Data Collection & Analysis
  • 7.4. Patient Recruitment & Screening
  • 7.5. Predictive Modeling
  • 7.6. Trial Design & Optimization

8. AI-based Clinical Trials Market, by Phase

  • 8.1. Introduction
  • 8.2. Phase-I
  • 8.3. Phase-II
  • 8.4. Phase-III

9. AI-based Clinical Trials Market, by Technology

  • 9.1. Introduction
  • 9.2. Machine Learning
  • 9.3. Natural Language Processing

10. AI-based Clinical Trials Market, by Application

  • 10.1. Introduction
  • 10.2. Cardiovascular Diseases
  • 10.3. Infectious Diseases
  • 10.4. Metabolic Diseases
  • 10.5. Neurological Diseases
  • 10.6. Oncology

11. AI-based Clinical Trials Market, by End-user

  • 11.1. Introduction
  • 11.2. Academic & Research Institutes
  • 11.3. Contract Research Organization
  • 11.4. Hospitals
  • 11.5. Pharmaceutical & Biopharmaceutical Companies

12. Americas AI-based Clinical Trials Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific AI-based Clinical Trials Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa AI-based Clinical Trials Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. FPNV Positioning Matrix
  • 15.2. Market Share Analysis, By Key Player
  • 15.3. Competitive Scenario Analysis, By Key Player

16. Competitive Portfolio

  • 16.1. Key Company Profiles
    • 16.1.1. AiCure, LLC
    • 16.1.2. Aiforia Technologies Oyj
    • 16.1.3. Antidote Technologies, Inc.
    • 16.1.4. Ardigen S.A.
    • 16.1.5. Avantor, Inc.
    • 16.1.6. BioAge Labs
    • 16.1.7. BioSymetrics Inc.
    • 16.1.8. Deep 6 AI Inc.
    • 16.1.9. Envisagenics
    • 16.1.10. Euretos Services BV
    • 16.1.11. Exscientia PLC
    • 16.1.12. GNS Healthcare
    • 16.1.13. Google LLC by Alphabet Inc.
    • 16.1.14. Innoplexus AG
    • 16.1.15. InSilico Medicine
    • 16.1.16. Intel Corporation
    • 16.1.17. International Business Machines Corporation
    • 16.1.18. Koninklijke Philips N.V.
    • 16.1.19. Median Technologies
    • 16.1.20. Nuritas Limited
    • 16.1.21. Pharmaceutical Pipeline Enhancement Strategies, LLC
    • 16.1.22. Saama Technologies, Inc.
    • 16.1.23. Symplr Software LLC
    • 16.1.24. Trials.ai, Inc. by ZS Associates, Inc.
    • 16.1.25. Unlearn.AI, Inc.
  • 16.2. Key Product Portfolio

17. Appendix

  • 17.1. Discussion Guide
  • 17.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. AI-BASED CLINICAL TRIALS MARKET RESEARCH PROCESS
  • FIGURE 2. AI-BASED CLINICAL TRIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AI-BASED CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AI-BASED CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AI-BASED CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AI-BASED CLINICAL TRIALS MARKET DYNAMICS
  • FIGURE 7. AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 10. AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 12. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 14. AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 16. AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 18. AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 22. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 27. AI-BASED CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 28. AI-BASED CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AI-BASED CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AI-BASED CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AI-BASED CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 6. AI-BASED CLINICAL TRIALS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AI-BASED CLINICAL TRIALS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 9. AI-BASED CLINICAL TRIALS MARKET SIZE, BY ADVERSE EVENT DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AI-BASED CLINICAL TRIALS MARKET SIZE, BY DATA COLLECTION & ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PATIENT RECRUITMENT & SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PREDICTIVE MODELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AI-BASED CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN & OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 15. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE-I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE-II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE-III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. AI-BASED CLINICAL TRIALS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AI-BASED CLINICAL TRIALS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AI-BASED CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AI-BASED CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AI-BASED CLINICAL TRIALS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AI-BASED CLINICAL TRIALS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AI-BASED CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AI-BASED CLINICAL TRIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AI-BASED CLINICAL TRIALS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AI-BASED CLINICAL TRIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. AI-BASED CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 283. AI-BASED CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. AI-BASED CLINICAL TRIALS MARKET LICENSE & PRICING